Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 11, 2008, Pages 1125-1129

  Lupetti, A ^a,b   Van Dissel, J T ^a   Brouwer, C P J M ^c   Nibbering, P H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PISA   (Italy)

^c AM Pharma   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; HISTATIN 5; LACTOFERRIN; LACTOFERRIN 1-11; LACTOFERRIN 21-31; PEPTIDE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN DHVAR4; PROTEIN DHVAR5; UBIQUICIDIN 18-35; UBIQUICIDIN 29-41; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ERYTHROCYTES; HEMOLYSIS; HUMANS; HYPHAE; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; STAINING AND LABELING; TETRAZOLIUM SALTS; THIAZOLES;

EID: 55549110379     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0553-z     Document Type: Article

References (16)

1. MM McNeil SL Nash RA Hajjeh MA Phelan LA Conn BD Plikaytis DW Warnock 2001 Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997 Clin Infect Dis 33 641 647
2. SJ Lin J Schranz SM Teutsch 2001 Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 358 366
3. R Herbrecht DW Denning TF Patterson JE Bennett RE Greene JW Oestmann WV Kern KA Marr P Ribaud O Lortholary R Sylvester RH Rubin JR Wingard P Stark C Durand D Caillot E Thiel PH Chandrasekar MR Hodges HT Schlamm PF Troke B de Pauw Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 408 415
4. K Thevissen HH Kristensen BP Thomma BP Cammue IE François 2007 Therapeutic potential of antifungal plant and insect defensins Drug Discov Today 12 966 971
5. M Zasloff 2002 Antimicrobial peptides of multicellular organisms Nature 415 389 395
6. A Lupetti CP Brouwer SJ Bogaards MM Welling E de Heer M Campa JT van Dissel RH Friesen PH Nibbering 2007 Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection J Infect Dis 196 1416 1424
7. A Lupetti A Paulusma-Annema MM Welling S Senesi JT van Dissel PH Nibbering 2000 Candidacidal activities of human lactoferrin peptides derived from the N terminus Antimicrob Agents Chemother 44 3257 3263
8. FG Oppenheim T Xu FM McMillian SM Levitz RD Diamond GD Offner RF Troxler 1988 Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans J Biol Chem 263 7472 7477
9. EJ Helmerhorst IM Reijnders W van't Hof I Simoons-Smit EC Veerman AV Amerongen 1999 Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides Antimicrob Agents Chemother 43 702 704
10. PS Hiemstra MT van den Barselaar M Roest PH Nibbering R van Furth 1999 Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages J Leukoc Biol 66 423 428
11. CP Brouwer SJ Bogaards M Wulferink MP Velders MM Welling 2006 Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice Peptides 27 2585 2591
12. SM Levitz RD Diamond 1985 A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT J Infect Dis 152 938 945
13. EF Schippers C van't Veer S van Voorden CA Martina TW Huizinga S le Cessie JT van Dissel 2005 IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin Cytokines 29 215 228
14. MA Pfaller C Grant V Morthland J Rhine-Chalberg 1994 Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans J Clin Microbiol 32 506 509
15. van der Does AM, Bogaards SJ, van Dissel JT, Nibbering PH (2007) The antimicrobial peptide hLF1-11 enhances recognition and elimination of pathogens by macrophages. In: Program and abstracts of the VIIth International Conference on Lactoferrin. Abstract no. O-VIII-6, 50
16. A Lupetti A Paulusma-Annema MM Welling H Dogterom-Ballering CP Brouwer S Senesi JT van Dissel PH Nibbering 2003 Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species Antimicrob Agents Chemother 47 262 267